Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui You

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
The Laryngoscope|October 17, 2018
Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissectionYou-Ping Liu, Hao Li, Rui You, et al.
The Laryngoscope|February 26, 2026
Pedicled Inferior Turbinate-Nasal Floor and Septal Mucoperiosteal Flap Resurfacing for PRNNYu-Tong Liu, Heng-Yu Ren, Zhao-Di Yuan, et al.
Cell Reports. Medicine|November 11, 2023
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trialSi-Yuan Chen, Xiao-Tong Duan, Hui-Feng Li, et al.
Cell Research|September 9, 2020
Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinomaShanzhao Jin, Ruoyan Li, Ming-Yuan Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2025
Radiation-induced rhinosinusitis in patients with nasopharyngeal carcinomaSi-Yuan Chen, Xiao-Tong Duan, Rui-Ling Xie, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2019
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trialQi Yang, Su-Mei Cao, Ling Guo, et al.
BMJ (Clinical Research Ed.)|February 10, 2026
Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trialRui You, Gui-Qiong Xu, Xi Ding, et al.
NEJM Evidence|April 22, 2025
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal CarcinomaPei-Yu Huang, Xu-Yin Chen, Xi Ding, et al.
JAMA Oncology|July 24, 2020
Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical TrialRui You, You-Ping Liu, Pei-Yu Huang, et al.
Nature Communications|February 5, 2023
Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significanceMei Lin, Xiao-Long Zhang, Rui You, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
The Laryngoscope|October 17, 2018
Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissectionYou-Ping Liu, Hao Li, Rui You, et al.
The Laryngoscope|February 26, 2026
Pedicled Inferior Turbinate-Nasal Floor and Septal Mucoperiosteal Flap Resurfacing for PRNNYu-Tong Liu, Heng-Yu Ren, Zhao-Di Yuan, et al.
Cell Reports. Medicine|November 11, 2023
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trialSi-Yuan Chen, Xiao-Tong Duan, Hui-Feng Li, et al.
Cell Research|September 9, 2020
Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinomaShanzhao Jin, Ruoyan Li, Ming-Yuan Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2025
Radiation-induced rhinosinusitis in patients with nasopharyngeal carcinomaSi-Yuan Chen, Xiao-Tong Duan, Rui-Ling Xie, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2019
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trialQi Yang, Su-Mei Cao, Ling Guo, et al.
BMJ (Clinical Research Ed.)|February 10, 2026
Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trialRui You, Gui-Qiong Xu, Xi Ding, et al.
NEJM Evidence|April 22, 2025
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal CarcinomaPei-Yu Huang, Xu-Yin Chen, Xi Ding, et al.
JAMA Oncology|July 24, 2020
Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical TrialRui You, You-Ping Liu, Pei-Yu Huang, et al.
Nature Communications|February 5, 2023
Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significanceMei Lin, Xiao-Long Zhang, Rui You, et al.
Pageof 18